Category Archives: Health: Mental Health

Mental Health Press Releases, bring us the latest cutting edge research, and therapies to help Mental Health in our modern society.

Scientific and Operational Recommendations, Upcoming Webinar Hosted by Xtalks


Join this webinar and learn from their experiences about what makes an excellent rater for these scales, how to take a targeted and tailored rater training approach based on common administration errors, and ways to catch rater drift before it becomes problematic. The presenters will also describe an approach called central rating that can increase quality and consistency while reducing site burden and heightening diversity.

Join experts from Cogstate, Kim Baldwin, Associate Director, Clinician Network; Felice Ockun, Senior Manager, Clinician Network, Clinical Trials; and Janelle Eloi, PhD, Principal Clinical Scientist, Licensed Neuropsychologist, for the live webinar on Wednesday, October 18, 2023, at 11am EDT (4pm BST/UK).

For more information, or to register for this event, visit Improve Data Reliability from MADRS and HAM-D Assessments in Clinical Trials: Scientific and Operational Recommendations.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, vkovacevic@xtalks.com

SOURCE Xtalks

Autistic-Led Organizations Receive Grants from NEXT for AUTISM


“As an autistic person, the fact that you are funding autistic-led opportunities, and giving autistic people the chance to be actively involved in programs that help them… it seems like such an obvious thing to do, but so few organizations do it. NEXT for AUTISM is one of the few that does it.”

– Dr. Rebecca Evanko, Wilderwood Equine Therapy

The seven 2023 grantees include:

  • Association for Autism and Neurodiversity (AANE): Peer mentoring for young autistic adults by experienced adults with autism
  • Autastic: Workshops and resources for newly diagnosed BIPOC autistic adults
  • Community for Autism and Motor Planning/TEVA Community: Retreats for non-speaking autistic adults and their families
  • Full Spectrum Agency for Autistic Adults: Peer support and time banking online platform for autistic adults below the poverty line
  • The Foundation for Life Guides for Autistics (LGFA): Helping autistic individuals understand their unique strengths to help them build a fulfilling life
  • Suffolk Street Creative: Supporting autistic adults socialize and build through a dance improv curriculum
  • Wilderwood Equine Therapy: Resource database for autism-friendly and approved services in rural New Mexico

NEXT follows a rigorous review process to identify and award grants. The external review committee for Color the Spectrum autistic-led grants is comprised solely of neurodivergent professionals. Each committee member utilizes a rubric to score applications based on pre-determined requirements, and with the goal that the grant works toward fulfilling NEXT’s vision that everyone deserves to lead a productive and fulfilling life. The committee then collectively discusses and scores the applications. Awards were funded by proceeds raised during NEXT for AUTISM’s 2021 COLOR THE SPECTRUM livestream event, in partnership with YouTube.

The 2024 grants cycle will open for applications in March 2024. Grant opportunities will be offered for autistic-led and community-led organizations.

Since 2008 NEXT’s grants program has funded more than 350 projects throughout the U.S., impacting 100,000 autistic individuals. For details on important dates, grant requirements, and more, please visit NEXTforAUTISM.org/grants. To connect with a member of the NEXT for AUTISM team, email [email protected] or call 212-759-3775.

ABOUT NEXT FOR AUTISM

NEXT for AUTISM transforms the national landscape of services for people with autism by strategically designing, launching, and supporting innovative programs. We believe that individuals with autism deserve to live fulfilling, productive lives when supported by excellent services and connected to their communities. We continually ask, what’s next for autism? Learn more at NEXTforAUTISM.org

Media Contact

Holly Wainwright, NEXT for AUTISM, 1 203-667-4734, [email protected], NEXTforAUTISM.org

SOURCE NEXT for AUTISM

Charting a New Path in Mental Healthcare with an Audacious Growth Vision


MEDvidi is addressing long-standing healthcare challenges to make healthcare more accessible, affordable, and efficient. Direct audio and video visits enable patients with limited access to healthcare services and those from remote areas to consult board-certified mental health professionals at a distance. Urgent needs are also solved with professional help delivered on-demand: instead of waiting for 4 to 8 weeks in traditional clinics, patients can book a video appointment within 24 hours. MEDvidi offers mental health care at an affordable cost without any hidden fees added on. MEDvidi also intends to establish in-person clinics nationwide while simultaneously pioneering innovative initiatives to advocate for Special Registration with the DEA, thereby enhancing the accessibility of mental healthcare. MEDvidi’s 2024 strategy includes plans to go beyond B2C and introduce B2B collaboration with offline clinics to ensure every patient can choose the most convenient and effective solution, which may include in-person consultations.

Thus far, MEDvidi has raised a substantial $2.8 million in investment capital, with participation from renowned investors including AltaIR Capital, TMT Investments, The Garage Syndicate, and Igor Shoifot. This significant investment reflects the high level of confidence these esteemed backers have in the company’s vision and growth potential.

Now MEDvidi strives to expand its horizons. A Total Addressable Market (TAM) of the US behavioral health market is estimated to reach $69 billion by 2028, and telehealth is a rapidly growing sector. The Serviceable Obtainable Market of MEDvidi is about $600M, and the company has set a goal to help tens of thousands of patients by the end of 2024. MEDvidi aims for geographic diversification and offers services across all states in the US. To reach the set objectives, the company also strives to address a wider range of healthcare needs, by offering Cognitive Behavioral Therapy (CBT) and a broader range of mental healthcare.

MEDvidi recognizes the importance of continuous innovation and relentless boundary-pushing of how telehealth services can best serve patients. Recently, the company introduced a new patient personal portal with expanded functionality where MEDvidi patients can book and reschedule appointments in a few taps and monitor treatment statuses in real-time.

CEO of MEDvidi, Vasili Razhnou remarked, “At the heart of MEDvidi is an unwavering commitment to our patients. As we navigate this exciting journey, our dual focus remains on technological evolution and nurturing a supportive community. We’re not just aiming to transform healthcare services; we’re setting out to reshape the narrative around mental health.”

The commitment to the latest advancements and personalized care allows the company to scale its growth and make healthcare less stigmatized and more accessible to a larger scope of people seeking help. In an era where healthcare demands new approaches, MEDvidi is also focused on building a supportive and positive community centered around mental health. As they continue to grow, their vision of accessible, efficient, and patient-centric healthcare is becoming a reality.

To learn more about MEDvidi, please visit www.medvidi.com.

About MEDvidi:

MEDvidi’s mission is to revolutionize the way individuals perceive, access, and engage with mental health care. They are committed to crafting an innovative online platform that not only nurtures emotional well-being but also offers personalized support while fostering a sense of community. Their driving purpose is to break down barriers to mental health care by providing accessible, affordable, and stigma-free services to individuals across the United States.

Media Contact

Stephanie Hall, Pitch Public Relations, 1 480-216-5422, [email protected], www.pitchpublicrelations.com

SOURCE MEDvidi

MP Biomedicals Announces Investment in a Biotechnology Campus in Solon, Ohio


Aaron Benz, Director of Operations, added “This will be a unique facility in that the production area is designed to be agile and pivot to changing manufacturing schemes due to market needs while remaining under strict controls. It will house our current chemical, reagent, and media manufacturing operations from our custom services, but will also support further expansion of our capabilities to include precision packaging of sensitive powdered biochemicals and the latest cell culture media capabilities.”

This new facility will include state of the art aseptic powder manufacturing suites, aseptic automated liquid manufacturing suites, aseptic and modular semi-automated liquid manufacturing suites, in-line automated filling manufacturing suites, and cell culture media production manufacturing suites. The facility will be registered with the US FDA and operate within a Quality Management System (QMS) certified to ISO13485:2016 and compliant with 21 CFR 210, 211, and 820. This will position MP Biomedicals to better support the current and future needs of the ever-evolving life science industry, its life science manufacturing customers, and will provide a seamless experience from research and development through commercialization that ensures access to the quality products, services, and expertise expected from MP Biomedicals.

To learn more about MP Biomedicals, the industries it serves, or to learn more about this new facility and how to benefit from it, please contact MP Biomedicals at [email protected], 800.854.0530, or chat via the website at www.mpbio.com/us.

MP Biomedicals is a global life science company with headquarters in California and regional offices across the globe. The company fuels research, development, and commercialization to advance life sciences that improve the human condition. Over the past 50 years, they have provided high quality products and expert services to assist their customers in making breakthrough discoveries and achieving scientific excellence.

Media Contact

Aaron Schieving, MP Biomedicals, 1 440.561.7069, [email protected], https://www.mpbio.com/us

SOURCE MP Biomedicals

Viewpoint will Partner with Oncologists and Physicians to Explore the Evolution of Head and Neck Cancer Treatment


The production team behind Viewpoint is dedicated to delivering a comprehensive and informative exploration of Head and Neck cancer treatment, aiming to increase awareness and understanding. Viewers can expect to gain valuable insights into the latest advancements in surgery, radiation therapy, chemotherapy, immunotherapy, and other cutting-edge treatments.

The collaboration with reputable oncologists and physicians will offer a unique perspective on the evolving landscape of Head and Neck cancer treatment, highlighting the importance of early detection, patient care, and the promise of improved outcomes.

Viewpoint’s production team is currently in the planning stages for this pivotal episode, which is set to air at a later date in 2024. The show will provide viewers with an opportunity to hear directly from experts in the field and to gain a deeper understanding of the progress being made in the fight against Head and Neck cancers.

About Viewpoint:

Viewpoint is a nationally recognized television program hosted by Dennis Quaid that delves into a wide range of compelling and informative topics. With a commitment to delivering thought-provoking content, Viewpoint has become a trusted source for in-depth discussions on issues that matter most to viewers.

Media Contact

Development Division, Viewpoint with host Dennis Quaid, 561-244-7620, [email protected], www.viewpointproject.com

SOURCE Viewpoint with host Dennis Quaid

Northeast Delta HSA to host mental health art exhibition in Lincoln Parish, Ruston Artisans


“Through this initiative, we commissioned seven regional creatives to develop artwork from their perspective, focusing on mental illness and addiction,” Dr. Sizer said. “We intend to help create an environment where dreams are realized, families are strong, bodies are healthy, community institutions are thriving, and spirits are renewed.”

Dr. Sizer sparked this creative expression to help address mental health issues, reduce addiction-related stigma, and work to transform the region’s economy.

Ruston Artisans is a fine art gallery, gift boutique, co-op, and event venue in historic downtown Ruston. It specializes in assisting the first-time, seasoned, and corporate art collector in connecting with that special piece that brings enjoyment and enhancement to a home or business. Ruston Artisans also brings art and people together for engagement, discovery, learning, and opportunity. It is committed to creating a place where local and international art is exhibited and sold, and local artists are promoted and supported through exhibitions and programs that strengthen and sustain our community. Ruston Artisans provides consulting services to artists, private and corporate collectors, as well as first-time art buyers. The Ruston Artisans event venue offers the opportunity to experience and celebrate all of the arts, including culinary, entertaining, fashion, film, literature, media, music, and performance.

Ruston Artisans Co-Founder Judith Null said they are “so honored to partner with NEDHSA to showcase this very important exhibition.”

“This initiative is a theme we have embraced since we opened our gallery. We believe in the intrinsic power of art to bring about mental, emotional, physical, and spiritual healing,” Null said. “To celebrate this theme, we encourage you to participate in our Open Studio to experience the therapeutic power of art. We invite the experienced and inexperienced patron, artist, and friend to experience this unique initiative and exhibition. Find your artistic expression at Ruston Artisans.”

The mental health art collection was created with the guidance and partnership of the NELA Arts Council and the Downtown Arts Alliance. The mental health exhibition displays pieces that introduce, inspire, and raise awareness of the various elements of mental/behavioral health, developmental disabilities, and addictive disorders. It features: “Joy is Coming” by JaCera Francois, “Verses of Sinners and Saints” by Keagan Vaughan, “Seen” by Rachel Madden, “Lose of Self” by Inique Harris, “Restored” by Shiketra’ Kween’ May White, “Intrusive Doubt” by Inique Harris, “What It Look Like 2.0 (Ease My Mind)” by Drék Davis, “What It Look Like 2.0 (So Many Tears)” by Drék Davis, “What It Look Like 2.0 (Stressed Out)” by Drék Davis, “What It Look Like 2.0 (Get Free)” by Drék Davis, “Growth” by Rachel Madden, “Fix Me” by Rachel Madden, and “Inside” by Rachel Madden.

The Ruston Artisans hours of operation are Wednesday-Thursday, 10 a.m. to 5 p.m., and Friday, 10 a.m. to 4 p.m., and is located at 203 W. Alabama Avenue, Ruston, La.

Contact the The Ruston Artisans at (318) 254-3322 for more information.

To confirm your attendance to the opening reception on Thursday, October 19, visit https://nedhsartshow2023.eventbrite.com.

Media Contact

DeRon Talley, NEDHSA, 318-237-9973, [email protected], www.nedeltahsa.org 

Twitter

SOURCE NEDHSA



Le mouvement #UseHeart (Utilisez votre cœur, en français) se mobilise pour faire évoluer les mentalités face à des maladies cardiovasculaires toujours plus meurtrières.



GENÈVE, 29 septembre 2023 /PRNewswire/ — À l’occasion de la Journée Mondiale du Cœur, la Fédération Mondiale du Cœur (FMC) appelle les entreprises de tous les secteurs mais également les citoyens à unir leurs forces pour que les maladies cardiovasculaires (MCV) ne soient plus la première…

BioCity Signs Collaboration Agreement with AstraZeneca on BC3402, a monoclonal antibody targeting anti-TIM-3, in Combination with IMFINZI (durvalumab) for the Treatment of Advanced Hepatocellular Carcinoma in China


WUXI, China, Sept. 27, 2023 /PRNewswire/ — September 25th, 2023, BioCity Biopharma and AstraZeneca signed an agreement to collaborate on a Phase Ib/II clinical study to evaluate the safety and efficacy of BioCity’s BC3402, a monoclonal antibody (mAb) targeting the T cell immunoglobulin…